Tetra Bio Pharma Inc V.TBP

Primary Symbol: TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > WELL IS IT A HOAX or MYSTERIOUS DISTRIBUTOR ON DECK!?

<< Previous

Bullboard Posts

Next >>

Comment by PCR1917on Dec 15, 2017 12:07pm

174 Views

Post# 27165523

RE:WELL IS IT A HOAX or MYSTERIOUS DISTRIBUTOR ON DECK!?

You know what Joe? It would make sense to me. I had this thought when they introduced the company on BNN: it would not have been worth to unveil who our partner was because not enough people knew about TBP anyway and it would not have had much impact. But now that more people are aware about TBP and have done their research, I think to have this news release next week would have much more impact considering yesterday's volume and the fact that many people are probably now waiting on the sidelines to see what happens.

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions